Advertisement

The insulin-like growth factors, their receptors, and their binding proteins in human breast cancer

  • Douglas Yee
  • Neal Rosen
  • Roberto E. Favoni
  • Kevin J. Cullen
Chapter
Part of the Cancer Treatment and Research book series (CTAR, volume 53)

Abstract

The ability to grow breast cancer cells in vitro has lead to the identification of several polypeptide hormones that may regulate their growth. The insulin- like growth factors (IGFs) have been identified as potent mitogens for breast cancer cells in vitro and increasing evidence has suggested that the IGFs may have an important function in the proliferation of mammary epithelia. This chapter will examine the data that support a role for the IGFs in regulating the growth of breast cancer cells.

Keywords

Breast Cancer Cell Breast Cancer Cell Line Malignant Epithelial Cell Human Mammary Carcinoma Cell Line Western Ligand Blotting 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Daughaday WH, Rotwein P, 1989. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 10:68–91.PubMedCrossRefGoogle Scholar
  2. 2.
    Scott J, Cowell J, Robertson ME, Priestley LM, Wadey R, Hopkins B, Pritchard J, Bell GI, Rall LB, Graham CF, Knott TJ, 1985. Insulin-like growth factor-II gene expression in Wilms’ tumour and embryonic tissues. Nature 317:260–262.PubMedCrossRefGoogle Scholar
  3. 3.
    Jansen M, VanSchaik FMA, Richer AT, Bullock B, Woods DE, Gabbay KH, Nussbaum AL, Sussenbach JS, Van den Brande JL, 1983. Sequence of cDNA encoding human insulin-like growth factor I precursor. Nature 306:604–611.CrossRefGoogle Scholar
  4. 4.
    Hudson P, John M, Crawford R, Haralambidis J, Scanlon D, Gorman J, Tregear G, Shine J, Niall H, 1984. Relaxin gene expression in human ovaries and the predicted structure of a human preprorelaxin by analysis of cDNA clones. EMBO J 3:2333–2339.PubMedGoogle Scholar
  5. 5.
    Han VKM, Lund PK, Lee DC, D’Ercole AJ, 1988. Expression of somatomedin/insulin-like growth factor messenger ribonucleic acids in the human fetus: Identification, characterization, and tissue distribution. J Clin Endocrinol Metab 66:422–429.PubMedCrossRefGoogle Scholar
  6. 6.
    D’Ercole AJ, Hill DJ, Strain AJ, Underwood LE, 1986. Tissue and plasma somatomedin-C/insulin-like growth factor-I concentrations in the human fetus during the 1st half of gestation. Pediatr Res 20:253–255.CrossRefGoogle Scholar
  7. 7.
    Romanus JA, Yang YW-H, Adams SO, Sofair AN, Tseng LT-H, Nissley SP, Rechler MM, 1988. Synthesis of insulin-like growth factor II (IGF-II) in fetal rat tissues: Translation of IGF-II ribonucleic acid and processing of pre-pro-IGF-II. Endocrinology 122: 709–716.PubMedCrossRefGoogle Scholar
  8. 8.
    Frunzio R, Chiariotti L, Brown AL, Graham DE, Rechler MM, Bruni CB, 1986. Structure and expression of the rat insulin-like growth factor II (rIGF-II) gene, rIGF-II RNAs are transcribed from two promoters. J Biol Chem 261:17138–17149.PubMedGoogle Scholar
  9. 9.
    Blum WF, Ranke MB, Bierich JR, 1986. Isolation and partial characterization of 6 somatomedin-like peptides from human plasma Cohn fraction IV. Acta Endocrinol 111: 271–284.PubMedGoogle Scholar
  10. 10.
    Gowan LK, Hampton B, Hill DJ, Schlueter RJ, Perdue JF, 1987. Purification and characterization of a unique high molecular weight form of insulin-like growth factor II. Endocrinology 121:449–458.PubMedCrossRefGoogle Scholar
  11. 11.
    Ullrich A, Gray A, Tarn AW, YangFeng T, Tsubokawa, M, Collins C, Henzel W, LeBon T, Kathuria, S, Chen E, Jacobs S; Francke U, Ramachandran J, Fujita-Yamaguchi Y, 1986. Insulin-like growth factor I receptor primary structure: Comparison with insulin receptor suggests structural determinants that define hormonal specificity. Embo J 5:2503–2512.PubMedGoogle Scholar
  12. 12.
    McDonald RG, Pfeffer SR, Coussens L, Tepper MA, Brocklebank CM, Mole JE, Anderson JK, Chen E, Czech MP, Ullrich A, 1988. A single receptor binds both insulin-like growth factor II and mannose-6-phosphate. Science 239:1134–1137.CrossRefGoogle Scholar
  13. 13.
    Morgan DO, Edman JC, Standring DN, Fried VA, Smith MC, Roth RA, Rutter WJ, 1987. Insulin-like growth factor II receptor as a multifunctional binding protein. Nature 329:301–307.PubMedCrossRefGoogle Scholar
  14. 14.
    Roth RA, 1988. Structure of the receptor for insulin-like growth factor II: The puzzle amplified. Science 239:1269–1271.PubMedCrossRefGoogle Scholar
  15. 15.
    Baxter RC, Martin JL, 1989. Binding proteins for the insulin-like growth factors: Structure, regulation and function. Prog Growth Factor Res 1:49–68.PubMedCrossRefGoogle Scholar
  16. 16.
    Wood WI, Cachianes G, Henzel WJ, Winslow GA, Spencer SA, Hellmiss R, Martin JL, Baxter RC, 1988. Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein. Mol Endocrinol 2:1176–1185.PubMedCrossRefGoogle Scholar
  17. 17.
    Lee YL, Hintz RL, James PM, Lee PDK, Shively JE, Powell DR, 1988. Insulin-like growth factor (IGF) binding protein cDNA from human HEP G2 hepatoma cells: Predicted protein sequence suggests an IGF binding domain different from those of the IGF-I and IGF-II receptors. Mol Endocrinol 2:404–411.PubMedCrossRefGoogle Scholar
  18. 18.
    Brewer M, Stetler GL, Squires CH, Thompson RC, Busby WH, Clemmons DR, 1988. Cloning, characterization, and expression of a human insulin-like growth factor binding protein. Biochem Biophys Res Comm 152:1289–1297.PubMedCrossRefGoogle Scholar
  19. 19.
    Busby WH Jr, Klapper DG, Clemmons DR, 1988. Purification of a 31,000-dalton insulin-like growth factor binding protein from human amniotic fluid, isolation of two forms with different biological actions. J Biol Chem 263:14203–14210.PubMedGoogle Scholar
  20. 20.
    De Mellow JSM, Baxter RC 1988. Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. Biochem Biophys Res Comm 156:199–204.PubMedCrossRefGoogle Scholar
  21. 21.
    Yee D, Cullen KJ, Paik S, Perdue JF, Hampton B, Schwartz A, Lippman ME, Rosen N, 1988. Insulin-like growth factor II mRNA expression in human breast cancer. Cancer Res 48:6691–6696.PubMedGoogle Scholar
  22. 22.
    Myal Y, Shiu RPC, Bhaumick B, Bala M, 1984. Receptor binding and growth-promoting activity of insulin-like growth factors in human breast cancer cells (T-47D) in culture. Cancer Res 44:5486–5490.PubMedGoogle Scholar
  23. 23.
    Furlanetto RW, DiCarlo JN, 1984. Somatomedin-C receptors and growth effects in human breast cells maintained in long term tissue culture. Cancer Res 44:2122–2128.PubMedGoogle Scholar
  24. 24.
    Zugmaier G, Knabbe C, Beschauer B, Ennis BW, Lippman ME, Dickson RB, 1989. Estradiol is synergistic with IGF1 or EGF to stimulate anchorage independent growth of estrogen receptor positive human breast cancer cells in serum supplemented but not in serum free agar. J Cell Biochem S13B, Abs E450.Google Scholar
  25. 25.
    DeLeon DD, Bakker B, Wilson DM, Hintz RL, Rosenfeld RG, 1988. Demonstration of insulin-like growth factor (IGF-I and-II) receptors and binding protein in human breast cancer cell lines. Biochem Biophys Res Comm 152:398–405.CrossRefGoogle Scholar
  26. 26.
    Cullen KJ, Yee D, Sly WS, Perdue J, Hampton B, Lippman ME, Rosen N, 1990. Insulin-like growth factor receptor expression and function in human breast cancer 50:48–53.Google Scholar
  27. 27.
    Flier JS, Usher P, Moses AC, 1986. Monoclonal antibody to the type I insulin-like growth factor (IGF-I) receptor blocks IGF-I receptor-mediated DNA synthesis: Clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblasts. Proc Natl Acad Sci USA 83:664–668.PubMedCrossRefGoogle Scholar
  28. 28.
    Rohlik QT, Adams D, Kull FC Jr, Jacobs S, 1987. An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue culture. Biochem Biophys Res Comm 149:276–281.PubMedCrossRefGoogle Scholar
  29. 29.
    Arteaga CL, Kitten L, Coronado EB, Jacobs S, Kull FC, Osborne CK, 1989. Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. J Clin Invest 84:1418–1423.PubMedCrossRefGoogle Scholar
  30. 30.
    Murphy LJ, Friesen HG, 1988. Differential effects of estrogen and growth hormone on uterine and hepatic insulin-like growh factor I gene expression in the ovariectomized hypohysectomized rat. Endocrinology 122:325–332.PubMedCrossRefGoogle Scholar
  31. 31.
    Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF, 1989. Studies of HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707–712.PubMedCrossRefGoogle Scholar
  32. 32.
    Pollack MN, Perdue JF, Margolese RG, Baer K, Richard M, (1987). Presence of somatomedin receptors on human breast and colon carcinomas. Cancer lett 38:223–230.CrossRefGoogle Scholar
  33. 33.
    Peyrat J-P, Bonneterre J, Beuscart J, Dijane J, Demaille A, 1988. Insulin-like growth factor I receptors in human breast cancer and their relation to estradiol and progesterone receptors. Cancer Res 48:6429–6433.PubMedGoogle Scholar
  34. 34.
    Peyrat JP, Bonneterre J, Laurent JC, Louchez MM, Amrani S, Leroy-Martin B, Vilain MO, Delobelle A, Demaille A, 1988. Presence and characterization of insulin-like growth factor 1 receptors in human benign breast disease. Eur J Cancer Clin Oncol 24:1425–1431.PubMedCrossRefGoogle Scholar
  35. 35.
    Huff KK, Kaufman D, Gabby KH, Spencer EM, Lippman ME, Dickson RB, 1986. Secretion of an insulin-like growth factor-I-related protein by human breast cancer cells. Cancer Res 46:4613–4619.PubMedGoogle Scholar
  36. 36.
    Minuto F, DelMonte P, Barreca A, Nicolin A, Giordano G, 1987. Partial characterization of somatomedin C-like immunoreactivity secreted by breast cancer cellsin vitro. Mol Cell Endo 54:179–184.CrossRefGoogle Scholar
  37. 37.
    Osborne CK, Ross CR, Coronado EB, Fuqua SA, Kitten LJ, 1988. Secreted growth factors from estrogen receptor-negative human breast cancer do not support growth of estrogen receptor-positive breast cancer in the nude mouse model. Breast Cancer Res Treat 11:211–219.PubMedCrossRefGoogle Scholar
  38. 38.
    Yee D, Paik S, Lebovic GS, Marcus RR, Favoni RE, Cullen KJ, Lippman ME, Rosen N, 1989. Analysis of IGF-I gene expression in malignancy, evidence for a paracrine role in human breast cancer. Mol Endocrlrol 3:509–517.CrossRefGoogle Scholar
  39. 39.
    Peres R, Betsholtz C, Westermark B, Heldin C-H, 1987. Frequent expression of growth factors for mesenchymal cells in human mammary carcinoma cell lines. Cancer Res 47:3425–3429.PubMedGoogle Scholar
  40. 40.
    Cullen KJ, Lippman ME, 1989. Estrogen regulation of protein synthesis and cell growth in human breast cancer. In Vitamins and Hormones, Vol 45, (Aurbach GD, ed) New York: Academic Press.Google Scholar
  41. 41.
    Brünner N, Cullen KJ, Yee D, Spang-Thomsen M, Lippman ME, Rosen N, Gelman E, Kern FG, 1989. Differential regulation by estradiol (E2) of IGF-I and IGF-II mRNA expression during E2-induced growth inhibition of the T61 human breast cancer xenograft. Proc Endocr Soc A288.Google Scholar
  42. 42.
    Travers MT, Barrett-Lee PJ, Berger U, Luqmani YA, Gazet J-C, Powles TJ, Coombes RC, 1988. Growth factor expression in normal, benign, and malignant breast tissue. Br Med J 296:1621–1624.CrossRefGoogle Scholar
  43. 43.
    Han VKM, D’Ercole AJ, Lund PK, 1987. Cellular localization of somatomedin messenger RNA in the human fetus. Science 236:193–197.PubMedCrossRefGoogle Scholar
  44. 44.
    Copeland KC, 1988. Effects of acute high dose and chronic low dose estrogen on plasma somatomedin-C and growth in patients with Turner’s syndrome. J Clin Endocrinol Metab 66:1278–1282.PubMedCrossRefGoogle Scholar
  45. 45.
    Colletti RB, Roberts JD, Devlin JT, Copeland KC, 1989. Effect of tamoxifen on plasma insulin-like growth factor I in patients with breast cancer. Cancer Res 49:1882–1884.PubMedGoogle Scholar
  46. 46.
    DeLeon DD, Wilson DM, Bakker B, Lamsom G, Hintz RL, Rosenfeld RG, 1989. Characterization of insulin-like growth factor (IGF) binging proteins from human breast cancer cells. Mol Endocrinol 3:567–574.CrossRefGoogle Scholar
  47. 47.
    Yee D, Favoni RE, Lupu R, Cullen KJ, Lebovic GS, Huff KK, Lee PDK, Lee YL, Powell DR, Dickson RB, Rosen N, Lippman ME, 1989. The insulin-like growth factor binding protein BP-25 is expressed by human breast cancer cells. Biochem Biophys Res Comm 158:38–44.PubMedCrossRefGoogle Scholar
  48. 48.
    Elgin RG, Busby WH Jr, Clemmons DR, 1987. An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. Proc Natl Acad Sci USA 84:3254–3258.PubMedCrossRefGoogle Scholar
  49. 49.
    Favoni RE, Cubbage M, Powell DR, Lippman ME, Rosen N, Yee D, 1989. Multiple insulin-like growth factor binding proteins are produced by human breast cancer cells. Br Cancer Res Treat 14:A168.Google Scholar
  50. 50.
    Hossenlopp P, Seurin D, Seovia-Quinson B, Hardouin S, Binoxu, M, 1986. Analysis of serum insulin-like growth factor binding proteins using Western blotting: Use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 154:138–143.PubMedCrossRefGoogle Scholar
  51. 51.
    Rosenfeld RG, Pham H, Conover CA, Hintz RL, Baxter RC, 1989. Structural and immu-nological comparison of insulin-like growth factor binding proteins of cerebrospinal and amniotic fluids. J Clin Endocrinol Metab 68:638–646.PubMedCrossRefGoogle Scholar
  52. 52.
    Reichman E, Ball R, Groner B, Friis RR, 1989. New mammary epithelial and fibroblastic cell clones in coculture form structures competent to differentiate functionally. J Cell Biol 108:1127–1138.CrossRefGoogle Scholar
  53. 53.
    Bronzert DA, Pantazis P, Antoniades HN, Kasid A, Davidson N, Dickson RB, Lippman ME, 1987. Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines. Proc Natl Acad Sci 84:5763–5767.PubMedCrossRefGoogle Scholar
  54. 54.
    Peres R, Betsholtz C, Westermark B, Heldin C-H, 1987. Frequent expression of growth factors for mesenchymal cells in human mammary carcinoma cell lines. Cancer Res 47:3425–3429.PubMedGoogle Scholar
  55. 55.
    Clemmons DR, 1984. Multiple hormones stimulate the production of somatomedin by cultured human fibroblasts. J Clin Endo Metab 58:850–856.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • Douglas Yee
  • Neal Rosen
  • Roberto E. Favoni
  • Kevin J. Cullen

There are no affiliations available

Personalised recommendations